Detalhe da pesquisa
1.
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer.
Prostate
; 84(5): 473-478, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38149793
2.
Trimodal therapy effect on survival in urothelial vs non-urothelial bladder cancer.
BJU Int
; 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494989
3.
Peri- and post-operative outcomes of robot-assisted radical cystectomy after the implementation of the EAU guidelines recommendations for collecting and reporting complications at a high-volume referral center.
World J Urol
; 42(1): 270, 2024 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38679650
4.
Identifying low cancer-specific mortality risk lymph node-positive radical prostatectomy patients.
J Surg Oncol
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470523
5.
Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate-specific antigen concentrations.
Prostate
; 83(15): 1504-1515, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37545342
6.
Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the Dogma.
J Urol
; 210(1): 117-127, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37052480
7.
Magnetic resonance imaging (MRI) for local staging before salvage radical prostatectomy: a meta-analysis.
World J Urol
; 41(5): 1275-1284, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37019997
8.
Focal therapy for primary tumor and metastases in de novo or recurrent oligometastatic prostate cancer: current standing and future perspectives.
World J Urol
; 41(8): 2077-2090, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36183289
9.
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion?
World J Urol
; 41(11): 3231-3237, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36943477
10.
Oncological and perioperative outcomes of surgery with or without metastasis-directed therapy as part of a multimodal treatment in men with de-novo oligometastatic prostate cancer.
World J Urol
; 41(8): 2069-2076, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37326656
11.
Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1-2 prostate cancer at MRI-targeted biopsy: a multicenter analysis.
World J Urol
; 41(2): 427-434, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36534151
12.
Active surveillance in renal transplant patients with prostate cancer: a multicentre analysis.
World J Urol
; 41(3): 725-732, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36710292
13.
The impact of a second MRI and re-biopsy in patients with initial negative mpMRI-targeted and systematic biopsy for PIRADS ≥ 3 lesions.
World J Urol
; 41(11): 3357-3366, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37755520
14.
Optimal combination therapy for metastatic hormone-sensitive prostate cancer: new evidence, challenges and unanswered questions.
Curr Opin Urol
; 33(6): 445-451, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37603006
15.
Urinary continence in high-risk prostate cancer after robot-assisted radical prostatectomy.
Curr Opin Urol
; 33(6): 482-487, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646515
16.
Salvage lymphadenectomy after primary therapy with curative intent for prostate cancer.
Curr Opin Urol
; 33(4): 269-273, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37166270
17.
The role of nuclear medicine tracers for prostate cancer surgery: from preoperative to intraoperative setting.
Curr Opin Urol
; 33(6): 502-509, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37530704
18.
Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer.
BMC Urol
; 23(1): 153, 2023 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37777767
19.
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series.
Prostate
; 82(12): 1170-1175, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538401
20.
Grade and stage misclassification in intermediate unfavorable-risk prostate cancer radiotherapy candidates.
Prostate
; 82(10): 1040-1050, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365851